A four-step synthesis of the title compound (X b ) from p -tolylsulfonanilide has been described which proceeds in 35 per cent over-all yield via ethyl 2-acetyl-5-( N -tosylanilino)valerate (IV b ) and the N -tosyl derivative of X b (VII b ). That this synthetic route had considerable generality was shown with four other examples—namely, 2-amino-6-methyl-5-( p -nitroanilinopropyl)-4-pyrimidinol (X c ), 2-amino-5-( p -carbethoxyanilinopropyl)-6-methyl-4-pyrimidinol (X d ), 2-amino-5-(3-anilinopropyl)-6-benzyl-4-pyridiminol (XVII b ), and 2-amino-5-(3-anilinopropyl)-6-phenyl-4-pyrimidinol (XVII a ). XVII a and b were good inhibitors of rat liver folic reductase, being complexed five and two times better, respectively, than the substrate, folic acid. Since XVII a and b are 35 and 16 times better, respectively, than the 6-methylpyrimidine (X b ), the phenyl ring at the 6-position is probably an additional point of binding to the enzyme.